School of Nursing, Midwifery and Physiotherapy, University of Nottingham, Queen's Medical Centre, Derby Road, Nottingham NG7 2HA, UK.
BMC Med Ethics. 2012 Sep 27;13:25. doi: 10.1186/1472-6939-13-25.
Research is fundamental to improving the quality of health care. The need for regulation of research is clear. However, the bureaucratic complexity of research governance has raised concerns that the regulatory mechanisms intended to protect participants now threaten to undermine or stifle the research enterprise, especially as this relates to sensitive topics and hard to reach groups.
Much criticism of research governance has focused on long delays in obtaining ethical approvals, restrictions imposed on study conduct, and the inappropriateness of evaluating qualitative studies within the methodological and risk assessment frameworks applied to biomedical and clinical research. Less attention has been given to the different epistemologies underlying biomedical and qualitative investigation. The bioethical framework underpinning current regulatory structures is fundamentally at odds with the practice of emergent, negotiated micro-ethics required in qualitative research. The complex and shifting nature of real world settings delivers unanticipated ethical issues and (occasionally) genuine dilemmas which go beyond easy or formulaic 'procedural' resolution. This is not to say that qualitative studies are 'unethical' but that their ethical nature can only be safeguarded through the practice of 'micro-ethics' based on the judgement and integrity of researchers in the field.
This paper considers the implications of contrasting ethical paradigms for the conduct of qualitative research and the value of 'empirical ethics' as a means of liberating qualitative (and other) research from an outmoded and unduly restrictive research governance framework based on abstract prinicipalism, divorced from real world contexts and values.
研究是提高医疗质量的基础。规范研究的需求是明确的。然而,研究治理的官僚复杂性引发了人们的担忧,即旨在保护参与者的监管机制现在可能威胁到破坏或扼杀研究事业,尤其是当涉及敏感话题和难以接触的群体时。
对研究治理的批评大多集中在获得伦理批准的漫长延迟上,对研究进行的限制,以及在应用于生物医学和临床研究的方法学和风险评估框架内评估定性研究的不适当性。对生物医学和定性研究所依据的不同认识论关注较少。当前监管结构所依据的生物伦理框架与定性研究中所需的新兴、协商性微观伦理实践根本不一致。现实环境的复杂性和变化性带来了意想不到的伦理问题,偶尔还会出现超出简单或公式化“程序”解决的真正困境。这并不是说定性研究是“不道德的”,而是说只有通过基于实地研究人员的判断和诚信的“微观伦理”实践,才能保障其伦理性质。
本文考虑了对比伦理范式对定性研究进行的影响,以及“经验伦理学”作为一种手段的价值,这种手段可以将定性(和其他)研究从基于抽象原则、脱离现实背景和价值观的过时和过度限制的研究治理框架中解放出来。